Floatz logo

Romiplostim

Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Centerprotein_peptidePhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
65/ 100

Competitive context

150 Active assets in the Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BBB
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
CARMUSTINE
VIVUS LLC
Phase 2BBB
Cytosin-Arabinosid
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB

View all 50 →

Same molecule, other indications

Romiplostim is also rated in:

ThrombocytopeniaDormant
BB
Indicative ·
70 / 100
View asset →
thrombocytopeniaDormant
BB
Indicative ·
65 / 100
View asset →
neoplasmDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →